Considering the important role of p53 for SPRY4 and the close relationship among p53, MDM2 and EZH2, it is interesting to find that EZH2 is an appropriate theoretical candidate target of SPRY4. EZH2 is highly expressed in various malignant tumors and is closely involved the occurrence and development of cancers. Here, TP53 is linked to cancer.